John Pallies joined Delta Projects as President and CEO in 2017 after a long career in the biotechnology and high-technology fields. Prior to joining Delta Projects, John was Chief Financial Officer of TCR2 Therapeutics, a Cambridge-based biotechnology company, and Syndax Pharmaceuticals, a venture- backed biotechnology company that went public in 2015 under his direction.
John was a volunteer Big Brother with Big Brothers of Mass Bay for ten years and has been an active volunteer for a number of other organizations including Hands on Bay Area, Boston Cares, St. Bernard Project and Special Olympics. John earned a B.S. in Marketing from Boston College and an M.B.A. from the Carroll School of Management at Boston College.